Allergan Botox Case Should Be Killed, Del. High Court Says

Law360, New York (April 5, 2013, 7:03 PM EDT) -- Delaware's Supreme Court on Friday reversed a controversial lower court decision that kept alive a derivative suit against Botox maker Allergan Inc., saying the case should have been tossed based on the dismissal of an almost-identical suit in California.

A five-judge panel said that Vice Chancellor J. Travis Laster erred in refusing to dismiss the suit, which targeted Allergan directors over alleged off-label marketing of the anti-wrinkle drug that led to a $600 million settlement with the U.S. Department of Justice. The high court said Vice...
To view the full article, register now.